Infectious Diseases Associates of Central Virginia
Lynchburg, Virginia, United States
Doctor in Lynchburg, Virginia
2215 Landover Pl, Lynchburg, VA 24501
About Infectious Diseases Associates of Central Virginia
"Welcome to Medical Associates Of Central Virginia, located in Lynchburg, VA! Your health and wellness is our number one priority, and we are committed to providing you with the best care possible. Schedule an appointment with us online or call us at (434) 947-3944. You can also access your account, pay a bill, or schedule an appointment using our myPrivia mobile app."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Infectious Diseases Associates of Central Virginia
During the past decade, Infectious Diseases Associates of Central Virginia conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
2005-12-01
2008-12-01
Completed
237
Expanded Access Program for Maraviroc At Multiple Centers
2007-02-01
2010-06-01
Completed
1,047
Prospective Observational Epidemiologic Study of Maraviroc's Safety
2008-03-31
2019-02-14
Completed
2,500
Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing
2014-02-01
2015-12-01
Completed
352
SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence
2016-08-01
2018-08-01
Completed
96
A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19
2020-08-02
2021-02-02
Completed
350
A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain
2020-07-01
2023-08-11
Active, not recruiting
103
A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years
2021-06-30
2028-05-14
Recruiting
18,556
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Infectious Diseases Associates of Central Virginia" #1 sponsor was "ViiV Healthcare" with 2 trials, followed by "Bausch Health Americas, Inc." with 1 trials
sponsored, "Finch Research and Development LLC." with 1 trials sponsored, "Hologic, Inc." with 1 trials sponsored and "Janssen Research & Development, LLC"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Infectious Diseases Associates of Central Virginia"
#1 collaborator was "Pfizer" with 1 trials as a collaborator and "Pharm-Olam International" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Infectious Diseases Associates of Central Virginia
According to Clinical.Site data, the most researched conditions in "Infectious Diseases Associates of Central Virginia" are
"Clostridium Difficile Infection" (1 trials), "Clostridium Infections" (1 trials), "Covid19" (1 trials), "Diarrhea" (1 trials) and "HIV Infections" (1 trials). Many other conditions were trialed in "Infectious Diseases Associates of Central Virginia" in a lesser frequency.
Clinical Trials Intervention Types at Infectious Diseases Associates of Central Virginia
Most popular intervention types in "Infectious Diseases Associates of Central Virginia" are "Drug" (6 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "COVI-DROPS" (1 trials), "CP101" (1 trials), "D/C/F/TAF FDC" (1 trials) and "ExPEC9V" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Infectious Diseases Associates of Central Virginia
The vast majority of trials in "Infectious Diseases Associates of Central Virginia" are
10 trials for "All" genders.
Clinical Trials Status at Infectious Diseases Associates of Central Virginia
Currently, there are NaN active trials in "Infectious Diseases Associates of Central Virginia".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Infectious Diseases Associates of Central Virginia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Infectious Diseases Associates of Central Virginia, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".